Several lncRNAs have been proposed as oncogenic in lung cancer, including MALAT1 (a diagnostic and prognostic biomarker in NSCLC) [40], AK126698 (mediates cisplatin resistance in NSCLC) [41], and lncRNA-DQ786227 (implicated in chemical carcinogenesis) [42]. The gene discussed is MALAT1; the disease is non-small cell lung carcinoma.